BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16817213)

  • 1. A case of dysferlinopathy presenting choreic movements.
    Takahashi T; Aoki M; Imai T; Yoshioka M; Konno H; Higano S; Onodera Y; Saito H; Kimura I; Itoyama Y
    Mov Disord; 2006 Sep; 21(9):1513-5. PubMed ID: 16817213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies.
    Paradas C; Llauger J; Diaz-Manera J; Rojas-García R; De Luna N; Iturriaga C; Márquez C; Usón M; Hankiewicz K; Gallardo E; Illa I
    Neurology; 2010 Jul; 75(4):316-23. PubMed ID: 20574037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF.
    Diers A; Carl M; Stoltenburg-Didinger G; Vorgerd M; Spuler S
    Neuromuscul Disord; 2007 Feb; 17(2):157-62. PubMed ID: 17129727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies.
    Nguyen K; Bassez G; Bernard R; Krahn M; Labelle V; Figarella-Branger D; Pouget J; Hammouda el H; Béroud C; Urtizberea A; Eymard B; Leturcq F; Lévy N
    Hum Mutat; 2005 Aug; 26(2):165. PubMed ID: 16010686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of podocyte dysferlin expression is associated with minimal change nephropathy.
    Izzedine H; Brocheriou I; Eymard B; Le Charpentier M; Romero NB; Lenaour G; Bourry E; Deray G
    Am J Kidney Dis; 2006 Jul; 48(1):143-50. PubMed ID: 16797397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe respiratory and skeletal muscles involvement in a carrier of dysferlinopathy with chronic obstructive pulmonary disease.
    Fuschillo S; Torrente Y; Balzano G
    Respir Care; 2010 Aug; 55(8):1091-3. PubMed ID: 20667157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysferlin aggregation in limb-girdle muscular dystrophy type 2B/Miyoshi Myopathy necessitates mutational screen for diagnosis [corrected].
    Nilsson MI; Laureano ML; Saeed M; Tarnopolsky MA
    Muscle Nerve; 2013 May; 47(5):740-7. PubMed ID: 23519732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mutational and clinical features of Japanese patients with dysferlinopathy (Miyoshi myopathy and limb girdle muscular dystrophy type 2B)].
    Aoki M; Takahashi T
    Rinsho Shinkeigaku; 2005 Nov; 45(11):938-42. PubMed ID: 16447768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study.
    Kesper K; Kornblum C; Reimann J; Lutterbey G; Schröder R; Wattjes MP
    Acta Neurol Scand; 2009 Aug; 120(2):111-8. PubMed ID: 19154541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lariat branch point mutation in the dysferlin gene with mild limb-girdle muscular dystrophy.
    Sinnreich M; Therrien C; Karpati G
    Neurology; 2006 Apr; 66(7):1114-6. PubMed ID: 16606933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis.
    Lo HP; Cooper ST; Evesson FJ; Seto JT; Chiotis M; Tay V; Compton AG; Cairns AG; Corbett A; MacArthur DG; Yang N; Reardon K; North KN
    Neuromuscul Disord; 2008 Jan; 18(1):34-44. PubMed ID: 17897828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel founder mutation in the DYSF gene causing clinical variability in the Spanish population.
    Vilchez JJ; Gallano P; Gallardo E; Lasa A; Rojas-García R; Freixas A; De Luna N; Calafell F; Sevilla T; Mayordomo F; Baiget M; Illa I
    Arch Neurol; 2005 Aug; 62(8):1256-9. PubMed ID: 16087766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysferlinopathy in the Jews of the Caucasus: a frequent mutation in the dysferlin gene.
    Leshinsky-Silver E; Argov Z; Rozenboim L; Cohen S; Tzofi Z; Cohen Y; Wirguin Y; Dabby R; Lev D; Sadeh M
    Neuromuscul Disord; 2007 Dec; 17(11-12):950-4. PubMed ID: 17825554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in skeletal muscle expression of AQP1 and AQP4 in dystrophinopathy and dysferlinopathy patients.
    Au CG; Butler TL; Egan JR; Cooper ST; Lo HP; Compton AG; North KN; Winlaw DS
    Acta Neuropathol; 2008 Sep; 116(3):235-46. PubMed ID: 18392839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limb-girdle muscular dystrophy in the Netherlands: gene defect identified in half the families.
    van der Kooi AJ; Frankhuizen WS; Barth PG; Howeler CJ; Padberg GW; Spaans F; Wintzen AR; Wokke JH; van Ommen GJ; de Visser M; Bakker E; Ginjaar HB
    Neurology; 2007 Jun; 68(24):2125-8. PubMed ID: 17562833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with a non-dysferlin Miyoshi myopathy have a novel membrane repair defect.
    Jaiswal JK; Marlow G; Summerill G; Mahjneh I; Mueller S; Hill M; Miyake K; Haase H; Anderson LV; Richard I; Kiuru-Enari S; McNeil PL; Simon SM; Bashir R
    Traffic; 2007 Jan; 8(1):77-88. PubMed ID: 17132147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic dysferlin gene mutation carriers: characterization of two cases.
    Illa I; De Luna N; Domínguez-Perles R; Rojas-García R; Paradas C; Palmer J; Márquez C; Gallano P; Gallardo E
    Neurology; 2007 Apr; 68(16):1284-9. PubMed ID: 17287450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limb-girdle muscular dystrophy due to emerin gene mutations.
    Ura S; Hayashi YK; Goto K; Astejada MN; Murakami T; Nagato M; Ohta S; Daimon Y; Takekawa H; Hirata K; Nonaka I; Noguchi S; Nishino I
    Arch Neurol; 2007 Jul; 64(7):1038-41. PubMed ID: 17620497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation impact on dysferlin inferred from database analysis and computer-based structural predictions.
    Therrien C; Dodig D; Karpati G; Sinnreich M
    J Neurol Sci; 2006 Dec; 250(1-2):71-8. PubMed ID: 16996541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the DYSF mutational spectrum in a large cohort of patients.
    Krahn M; Béroud C; Labelle V; Nguyen K; Bernard R; Bassez G; Figarella-Branger D; Fernandez C; Bouvenot J; Richard I; Ollagnon-Roman E; Bevilacqua JA; Salvo E; Attarian S; Chapon F; Pellissier JF; Pouget J; Hammouda el H; Laforêt P; Urtizberea JA; Eymard B; Leturcq F; Lévy N
    Hum Mutat; 2009 Feb; 30(2):E345-75. PubMed ID: 18853459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.